Levobunolol is a beta-adrenergic antagonist used for the reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. A medication used to treat glaucoma and high blood pressure in the eye.
- Mechanism
- Curator reviewed
Levobunolol's mechanism of action in reducing IOP is not clearly defined, but is believed to be due to a reduction of the production of aqueous humor via blockage of endogenous catecholamine-stimulated increases in cyclic adenosine monophosphate (AMP) concentrations within the ciliary processes.
- Primary indication
- For lowering intraocular pressure (IOP) and may be used in patients with chronic open-angle glaucoma or ocular hypertension.Curator reviewed · 2 structured indications
- Formula / weight
- C17H25NO3 · 291.3853 g/mol (avg)
- First approval
- Canada, 1997 · United States, 1986
- Brand names
Resolves to
IXHBTMCLRNMKHZ-LBPRGKRZSA-NSMILESCC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Levobunolol, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account